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Finite supply of fossil resources, resource efficiency, carbon 
footprint. All of them are megatrends within international 
production environments. But how to measure 
environmental sustainability? What is the 
environmental impact of your Supply Chain? 
 
Innovative production technologies require cutting edge 
resource consumption assessment methods, e.g. based on 
thermodynamics. 
 
Exergy Analysis* (EA) at process (α) and plant (β)  
level 
Exergetic Life Cycle Analysis (ELCA) at overall 
industrial level (γ) 
  *Exergy: quantity and quality of both energetic and material 
           resources. One single resource-based indicator  pro-active 
 Continuous process optimisation through analysis of     
       thermodynamic imperfections 
 
 
  
 
 
 
 
 
 
 
 
Resource-based environmental sustainability assessment and LCA enables quantifying and 
eventually controlling your environmental impact through process improvements. In contrast 
to traditionally emission-based studies, a direct correlation between avoided resource 
consumption and cost reduction is likely to be present. The obtained eco indicators are a 
powerful instrument in stakeholder communications. 
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Results: 
• API dose (Active Pharmaceutical Ingredient) most sensitive 
parameter (10% reduction API dose  7% resource consumption 
reduction) 
• Process improvements through valorisation of treated wastewater 
(e.g. cooling media) and exhaust air heat recuperation  33% 
reduction of exergy losses 
 
Economic point of view: 
• Direct cost reduction (26% resource consumption reduction)  
Lean Manufacturing 
• Corporate Sustainability Reporting 
• Marketing, communications 
• Meeting (European) legislations and voluntary initiatives 
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Results: 
• 34%, 26% and 15% resource consumption 
reduction at process (α), plant (β) and 
industrial (γ) level respectively by implementing  
continuous manufacturing line 
• Resource footprint: 65% fossil resources, 15% 
water resources, 15% land occupation and 
biomass production, 5% renewable resources 
 
 
